Innosuisse is the Swiss agency for promotion of innovation, legally mandated to promote science-based innovation and start-ups in Switzerland. From Wikipedia
An Innosuisse grant will let PSI’s radiopharmaceutical scientists refine a CD30-targeted terbium-161 therapy before initial human trials.
